Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Medium chain fatty acids are commonly consumed as part of diets for endurance sports and as medical treatment in ketogenic diets where these diets regulate energy metabolism and increase adenosine levels. However, the role of the equilibrative nucleoside transporter 1 (ENT1), which is responsible for adenosine transport across membranes in this process, is not well understood. Here, we investigate ENT1 activity in controlling the effects of two dietary medium chain fatty acids (decanoic and octanoic acid), employing the tractable model system Dictyostelium. We show that genetic ablation of three ENT1 orthologues unexpectedly improves cell proliferation specifically following decanoic acid treatment. This effect is not caused by increased adenosine levels triggered by both fatty acids in the presence of ENT1 activity. Instead, we show that decanoic acid increases expression of energy-related genes relevant for fatty acid β-oxidation, and that pharmacological inhibition of ENT1 activity leads to an enhanced effect of decanoic acid to increase expression of tricarboxylicacid cycle and oxidative phosphorylation components. Importantly, similar transcriptional changes have been shown in the rat hippocampus during ketogenic diet treatment. We validated these changes by showing enhanced mitochondria load and reduced lipid droplets. Thus, our data show that ENT1 regulates the medium chain fatty acid-induced increase in cellular adenosine levels and the decanoic acid-induced expression of important metabolic enzymes in energy provision, identifying a key role for ENT1 proteins in metabolic effects of medium chain fatty acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, DA treatment has been shown to enhance mitochondrial complex I activity and increase mitochondrial numbers, supporting neuronal health (Hughes et al., 2014; Pain et al., 2024).”
From Decanoic acid extends lifespan and modulates metabolism in models of PLA2G6 -associated neurodegeneration (2025) · cites this paper as Pain et al., 2024
In the citing paper
“The alterations in adenosine levels upon DA treatment (Pain et al., 2024) indicate that DA may be modulating purine metabolism, potentially offering therapeutic benefits by restoring metabolic balance and reducing oxidative stress, likely contributing to the lifespan extension observed in PLAN flies treated with DA.”
From Decanoic acid extends lifespan and modulates metabolism in models of PLA2G6 -associated neurodegeneration (2025) · cites this paper as Pain et al., 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The genome of the social amoeba Dictyostelium discoideum
Eichinger, L., Pachebat, J. A., Glöckner, G., Rajandream, M.-A., Sucgang, R., Berriman, M., Song, J., Olsen, R., Szafranski, K., Xu, Q., et al. (2005) · Nature · doi:10.1038/nature03481 · Cited by 1,351
AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797 · cited 1×
“Glucose reduction triggers a low energetic state, leading to AMPK activation to inhibit cell growth via reduced activity of mTORC1, and high glucose levels reverse this process, and this mechanism is highly conserved in eukaryotes ( 58 , 59 ).”
BackgroundAnticonvulsant Mechanisms of the Ketogenic Diet
Bough, K. J., & Rho, J. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00915.x · Cited by 523
Wang, Y., Liu, Z., Han, Y., Xu, J., Huang, W., & Li, Z. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191182 · Cited by 62
Research works printed but not linked: 60
- M. Alves-Bezerra, D. E. Cohen, Triglyceride metabolism in the liver. Compr. Physiol. 8, 1–8 (2017).
- 10.1186/s12970-018-0265-4 · DOI
- D. C. H. Cj, G. M. Schofield, M. Williden, J. A. McQuillan, The effect of medium chain triglycerides on time to nutritional ketosis and symptoms of keto-induction in healthy adults: A randomised controlled clinical trial. J. Nutr. Metab. 2018, 2630565 (2018).
- 10.1016/S1474-4422(17)30408-8 · DOI · Paper page
- 10.1111/j.1528-1167.2008.01821.x · DOI · Paper page
- 10.1016/j.eplepsyres.2011.05.021 · DOI
- 10.3389/fnins.2019.00005 · DOI · Paper page
- 10.1007/s11064-019-02795-4 · DOI
- 10.1192/bjo.2023.36 · DOI
- 10.1006/exnr.1999.7298 · DOI
- 10.1111/j.1528-1157.2000.tb00115.x · DOI · Paper page
- 10.1093/brain/awv325 · DOI · Paper page
- 10.1016/j.neuropharm.2018.01.011 · DOI · Paper page
- 10.1002/glia.23247 · DOI · Paper page
- 10.1111/epi.14578 · DOI
- 10.1073/pnas.2008980117 · DOI
- 10.1111/jnc.12646 · DOI · Paper page
- 10.1074/jbc.M111.294785 · DOI · Paper page
- 10.1038/s41598-021-85523-9 · DOI
- 10.1124/pr.112.006361 · DOI · Paper page
- 10.1111/j.1528-1167.2008.01771.x · DOI
- 10.3389/fnmol.2016.00026 · DOI
- 10.1016/j.neuropharm.2015.08.007 · DOI · Paper page
- 10.1172/JCI57813 · DOI · Paper page
- 10.1111/j.1528-1167.2009.02382.x · DOI
- 10.1046/j.1528-1157.2003.03603.x · DOI · Paper page
- 10.3389/fphar.2018.00627 · DOI
- 10.1007/s12017-014-8338-2 · doi:10.1007/s12017-014-8338-2
- 10.1111/j.1471-4159.2011.07242.x · DOI
- 10.1128/EC.00104-06 · DOI
- 10.1242/dmm.008029 · DOI
- 10.1242/dmm.035600 · DOI
- 10.1093/braincomms/fcab160 · doi:10.1093/braincomms/fcab160
- 10.1016/j.neuropharm.2012.11.004 · DOI · Paper page
- 10.1124/jpet.114.218768 · DOI · Paper page
- 10.1038/s41598-018-26756-z · DOI
- 10.1387/ijdb.190228rw · DOI
- 10.1080/15257770.2016.1210805 · DOI · Paper page
- 10.1021/bi015833w · doi:10.1021/bi015833w
- 10.1016/j.bbamem.2009.08.003 · DOI
- 10.1016/0005-2736(74)90239-9 · DOI · Paper page
- 10.1242/jcs.112.22.3995 · DOI · Paper page
- 10.1111/bph.14892 · DOI
- 10.1242/dmm.032375 · DOI
- 10.1093/toxsci/kfab097 · DOI
- 10.1078/0171-9335-00342 · DOI
- R. S. B. Williams, D. Boison, S. A. Masino, J. M. Rho, “Jasper’s basic mechanisms of the epilepsies” in Jasper’s Basic Mechanisms of the Epilepsies, J. L. Noebels, M. Avoli, M. A. Rogawski, A. Vezzani, A. V. Delgado-Escueta, Eds. (Mechanisms of Ketogenic Diet Action, Oxford University Press, 2024).
- 10.3390/cells9081914 · DOI
- 10.3389/fnins.2020.610898 · DOI
- 10.3390/cells10113036 · DOI
- 10.1038/srep40136 · doi:10.1038/srep40136
- 10.1007/s10545-016-9930-4 · DOI
- 10.1038/nrm3311 · DOI · Paper page
- 10.1038/nrm.2017.95 · DOI · Paper page
- 10.1006/abbi.1994.1058 · DOI
- 10.1002/ana.20899 · DOI · Paper page
- 10.3390/nu12082379 · DOI
- 10.1038/s41420-023-01462-6 · DOI
- 10.3390/metabo13010112 · DOI
- 10.2144/000114054 · doi:10.2144/000114054
Cited by
Zhang, B., Dunn, E., Williams, R. S. B., Snowden, S., & Augustin, H. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052184
Self-citation
Metadata
- Authors
- Pain, E., Snowden, S., Oddy, J., Shinhmar, S., Alhammad, Y. M. A., King, J. S., Müller-Taubenberger, A., & Williams, R. S. B.
- Affiliations
- Centre for Biomedical Sciences, Department of Biological Sciences, School of Life Sciences and the Environment, Royal Holloway University of London, Egham TW20 OEX, United Kingdom
- Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva 4 CH-1211, Switzerland
- Department of Biomedical Sciences, University of Sheffield, Sheffield S10 2TN, United Kingdom
- Department of Cell Biology, Biomedical Center, Ludwig Maximilian University of Munich, Planegg-Martinsried 82152, Germany
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2024-08-29
- Volume
- 121
- Issue
- 36
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 7
- References
- 4
- Language
- en
- Funders
- Vitaflo Ltd (N/A)
- BBSRC DTP studentship (N/A)
- UKRI | Biotechnology and Biological Sciences Research Council (B/V019368/1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression. https://app.cochat.ai/papers/10.1073/pnas.2321874121
- The paper
- Pain, E., Snowden, S., Oddy, J., Shinhmar, S., Alhammad, Y. M. A., King, J. S., Müller-Taubenberger, A., & Williams, R. S. B. (2024). Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2321874121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.